Genzyme Next-Generation Osteoarthritis Candidate Hylastan Found Not Superior To Steroids

Failed therapy is now on the back burner, as focus turns to approval and introduction of single-treatment viscosupplementation product Synvisc-One, company tells “The Pink Sheet” DAILY.